The week in review

With readers airing concerns about opportunistic testing for COVID-19 in pharmacy, this week saw a number of attitudes within the profession revealed

AJP polled readers to find out what you think of the proposal for opportunistic COVID-19 testing in pharmacy, and the results were clear: you’re not keen. Most readers said the idea would put patients and pharmacy workers at risk; PSA national president Chris Freeman said that members are already reporting people calling to see if they can get tested in pharmacy, while the Guild said the concept would be opt-in and involve safety measures.

The UTS Community Pharmacy Barometer showed the highest confidence within the profession in nearly a decade… based on a sample taken in November 2019, anyway. The Barometer also looked at how pharmacists feel about the “turf war” between the profession and GPs. And more perceptions were revealed by the Pharmacy Board, which released its report on how health professionals feel about AHPRA, including what pharmacists think of it and the Board.

Meanwhile PM Scott Morrison announced a deal between the Government and AstraZeneca to provide the University of Oxford COVID-19 vaccine for free, should trials prove successful… which AZ said was a good first step.

We took a look at the income generated by GP pharmacists, at the risk of GI bleeding with aspirin, audits for vaccinating pharmacies in NSW, and changes to Close The Gap scripts… which still leave hospital pharmacists out of the loop.

The Australian Digital Health Agency announced that pharmacies in the greater Melbourne region with software capability can now commence dispensing e-prescriptions, and PDL called for nominations for two Board members, with vacancies occurring as of the next PDL Annual General Meeting on Thursday the 19th of November 2020.

Previous Keeping supply going in Stage 4
Next An 'exciting, nerve-wracking' change

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply